EDITORIAL EXPERIENCE
2003-2019 Editor-In-Chief, Cancer Cell.
ACADEMIC EXPERIENCE
1995-2003 Assistant Professor, University of Texas M. D. Anderson Cancer Center
1993-1994 Research Associate, The Johns Hopkins University School of Medicine
1991-1993 Research Fellow (Oncology), The Johns Hopkins University School of Medicine, Dr. Bert Vogelstein
1989-1991 Post-Doctoral Fellow (Tumor Suppressors), Cold Spring Harbor Laboratory, Dr. Ed Harlow
1984-1989 Ph.D. (Molecular Biology), University of Pennsylvania, Dr. Tom Kadesch
1978-1980 M.S. (Molecular Biology), National Tsing-Hua University, Taiwan
1974-1978 B.S. (Pharmacy), Taipei Medical College (then)/Taipei Medical University (now), Taiwan
OTHER PROFESSIONAL ACTIVITIES
2000-2001 Tumor Cell Biology Review Committee, The Susan G. Komen Breast Cancer Foundation
1996 Molecular Biology 5 Review Panel, Department of Defense Breast Cancer Research Program
1990-1992 Post-doctoral fellowship, Damon Runyon-Walter Winchell Foundation.
SELECTED PUBLICATIONS
Bu, W., and Su, L-K. Characterization of functional domains of human EB1 family proteins. J. Biol. Chem., 278: 49721-49731, 2003.
Phillips, R. K., Wallace, M. H , Lynch, P. M , Hawk, E., Gordon, G. B., Saunders, B. P., Wakabayashi, N., Shen, Y., Zimmerman S., Godio, L., Rodrigues-Bigas, M., Su, L.-K., Sherman J., Kelloff G., Levin B., and Steinbach G.; FAP Study Group. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut, 50: 857-860, 2002
Wang, S. C., Shao, R., Pao, A. Y., Zhang, S., Hung, M. C., and Su, L.-K. Inhibition of cancer cell growth by BRCA2. Cancer Res., 62: 1311-1314, 2002.
Su, L.-K., Abdalla, E. K., Law, C. H., Kohlmann, W., Rashid, A., and Vauthey, J. N.. Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer, 92: 332-339, 2001.
Bu, W., and Su, L.-K. Regulation of microtubule assembly by human EB1 family proteins. Oncogene, 20: 3185-3192, 2001
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L.-K., and Levin, B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342: 1946-1952, 2000.
Su, L.-K., Barnes, C. J., Yao, W., Qi, Y., Lynch, P. M., and Steinbach, G. Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis. Am. J. Hum. Genet., 67: 582-590, 2000.
Su, L.-K., Wang, S. C., Qi, Y., Luo, W., Hung, M. C., and Lin, S. H. Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression. Oncogene, 17: 2377-2381, 1998.
Su, L.-K., Burrell, M., Hill, D. E., Gyuris, J., Brent, R., Wiltshire, R., Trent, J., Vogelstein, B., and Kinzler, K. W. APC binds to the novel protein EB1. Cancer Res., 55 2972-2977, 1995.
Su, L.-K., Vogelstein, B., and Kinzler, K. W. Association of the APC tumor suppressor protein with catenins. Science, 262: 1734-1737, 1993.
Herrmann, C. H., Su, L.-K., and Harlow, E. Adenovirus E1A is associated with a serine/threonine protein kinase. J. Virol., 65: 5848-5859, 1991.
Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., Hedge, P., Markham, A., Krush, A. J., Petersen, G., Hamilton, S. R., Nilbert, M. C., Levy, D. B., Bryan, T. M., Preisinger, A. C., Smith, K. J., Su, L.-K., Kinzler, K. W., and Vogelstein, B. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253: 665-669, 1991.
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., Finniear R., Matrkam, A., Groffen, J., Boguski, M. S., Altschul, S. F., Horii, A., Ando, H., Miyoshi, Y., Miki, Y., Nishisho, I., and Nakamura, Y.
Identification of FAP locus genes from chromosome 5q21. Science, 253: 661-665, 1991.
Su, L.-K., and Kadesch, T. The immunoglobulin heavy-chain enhancer functions as the promoter for I mu sterile transcription. Mol Cell Biol., 10: 2619-2624, 1990.